These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1743190)

  • 1. Preliminary European intravenous clinical experience with a new, low osmolar, nonionic contrast medium: ioversol (Optiray).
    Le Mignon MM; Azau C; Arthaud A; Bonnemain B
    Eur J Radiol; 1991; 13(2):126-33. PubMed ID: 1743190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical profile of ioversol. A metaanalysis of 57 randomized, double-blind clinical trials.
    Floriani I; Ciceri M; Torri V; Tinazzi A; Jahn H; Noseda A
    Invest Radiol; 1996 Aug; 31(8):479-91. PubMed ID: 8854194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of efficacy and tolerability of ioversol in intravenous urography. A comparative double-blind study versus iopamidol].
    Joffre F; Rousseau H; Aziza R
    Ann Radiol (Paris); 1992; 35(4 Pt 2):288-92. PubMed ID: 1296494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind clinical study comparing the safety, tolerance and efficacy of ioversol and iohexol in intravenous urography.
    Colthurst JR; Chan O; Creagh M; Gordon P; Guy R; Muncey F; Ayers AB
    Clin Radiol; 1990 Sep; 42(3):174-6. PubMed ID: 2208927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ioversol in ascending phlebography--a clinical trial.
    Scott H; Palmer FJ
    Australas Radiol; 1990 Feb; 34(1):44-6. PubMed ID: 2192700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ioversol clinical safety summary.
    Benamor M; Aten EM; McElvany KD; Lankin DG; James MA; Buy-Gandal T; Harashe LT; Weinandt WJ
    Invest Radiol; 1989 Jun; 24 Suppl 1():S67-72. PubMed ID: 2687200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ioversol 350: clinical experience in skull x-ray computed tomography].
    Théron J; Paugam JP; Courthéoux P
    Ann Radiol (Paris); 1991; 34(6-7):413-7. PubMed ID: 1822666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unequal doses of ioversol versus diatrizoate for urography.
    Baker MK; Kopecky KK; Bogan M; Wass JL
    Urol Radiol; 1990; 12(3):168-72. PubMed ID: 2281582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ioversol for intravenous urography: a comparison study.
    Kaufman AJ; Concepcion R; Kirchner FK; McDougal WS; Winfield AC
    Urol Radiol; 1990; 12(1):56-60. PubMed ID: 2333674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ascending lower limb phlebography: comparison of ioversol and iothalamate meglumine.
    Wilson AJ; Murphy WA; Destouet JM; Gilula LA; Hardy DC; Monsees B; Totty WG
    Can Assoc Radiol J; 1989 Jun; 40(3):142-4. PubMed ID: 2660958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ioversol in intravenous excretory urography. Evaluation of radiographic quality, patient tolerance and safety in four clinical studies.
    Jahn H; Müller-Späth R
    Ann Radiol (Paris); 1992; 35(4 Pt 2):297-302. PubMed ID: 1296496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of iopromide with iopamidol and iohexol for contrast-enhanced computed tomography.
    Goldberg SN; Abrahams J; Drayer BP; Golding S; Bernardino M; Brunetti J
    Invest Radiol; 1994 May; 29 Suppl 1():S76-83; discussion S93. PubMed ID: 8071050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind study of a new nonionic contrast agent for digital subtraction arteriography.
    Weiss JP; McLean GK; Modic MT; Rees CR; Higashida RT
    Invest Radiol; 1994 May; 29 Suppl 1():S84-92. PubMed ID: 8071051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical experience with ioversol for angiography.
    Bettmann MA
    Invest Radiol; 1989 Jun; 24 Suppl 1():S61-6. PubMed ID: 2687199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ioversol 320: a new nonionic, water-soluble contrast medium for body computed tomography clinical trial.
    Kopecky KK; Becker GJ; Conces DJ
    Invest Radiol; 1989 Jun; 24 Suppl 1():S33-4. PubMed ID: 2687192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical tolerability of ioversol 300 in brain computed tomography].
    Gillard C; Tatu L; Menegazzo D; Bonneville JF
    Ann Radiol (Paris); 1992; 35(4 Pt 2):284-7. PubMed ID: 1296493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of iopromide for excretory urography.
    Newhouse JH; Landman J; Lang E; Amis ES; Goldman S; Khazan R; Leder R; Hedgcock M
    Invest Radiol; 1994 May; 29 Suppl 1():S68-73. PubMed ID: 8071049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind comparative study on the contrast quality, tolerance and safety of ioversol 300 versus iohexol 300 in central venous angiography (C.V. DSA).
    Rieser R; Beinborn W; Ney N
    Ann Radiol (Paris); 1992; 35(4 Pt 2):311-4. PubMed ID: 1296499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ioversol 300: clinical study in pediatric intravenous urography].
    Montagne J; Adamsbaum C
    Ann Radiol (Paris); 1992; 35(4 Pt 2):307-10. PubMed ID: 1296498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacotoxicological profile of a non-ionic LOCM at high hydrophilicity: ioversol].
    Doucet D; Idée JM
    Ann Radiol (Paris); 1992; 35(4 Pt 2):267-72. PubMed ID: 1296489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.